Title:
核受容体の効能剤であるイソオキサゾール誘導体及びその用途
Document Type and Number:
Japanese Patent JP6886074
Kind Code:
B2
Abstract:
The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.
More Like This:
Inventors:
Jae Hoon Kang
Hong-Subee
Yoon-Sook Lee
Jin-A Jung
Sun-Uk Kwon
John-Gen Kim
Kyung-Sung Kim
Don-Kun Sung
Sun-Young Park
Kyo-Jin Kim
Ji-Hae Choi
Hay-Min Huang
Hong-Subee
Yoon-Sook Lee
Jin-A Jung
Sun-Uk Kwon
John-Gen Kim
Kyung-Sung Kim
Don-Kun Sung
Sun-Young Park
Kyo-Jin Kim
Ji-Hae Choi
Hay-Min Huang
Application Number:
JP2020506694A
Publication Date:
June 16, 2021
Filing Date:
April 12, 2018
Export Citation:
Assignee:
Ildon Pharmaceutical Company Limited
International Classes:
C07D261/08; A61K31/42; A61K31/422; A61K31/4439; A61K31/454; A61K31/455; A61K31/496; A61K31/498; A61K31/5377; A61P1/04; A61P1/16; A61P3/00; A61P3/06; A61P3/10; A61P9/10; A61P13/12; A61P17/00; A61P19/00; A61P29/00; A61P35/00; A61P35/02; A61P43/00; C07D413/12; C07D413/14
Domestic Patent References:
| JP2009538333A |
Foreign References:
| WO2009149795A1 |
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe